drugset / Trial / NCT03087162
Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori
RandomizedParallel-groupOpen-labelTreatment
Summary
New drug regimen for Helicobacter pylori eradication, the investigators compare once daily dose dexlansoprazole levofloxacin based quadruple therapy and twice daily dose dexlansoprazole levofloxacin quadruple therapy for helicobacter pylori eradication.
Timeline
- Start
- 2017-01-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexlansoprazole | Other / unclassified | 60 mg | Oral |
Indications
No indication recorded.